AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Neurobiological Technologies, Inc.

$0 +$0.00 (+0.00%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$0
Day Range
$0$0
Year Range
$0$0
Market Cap
2.7K
AVG Volume
1.53K
Trailing/Forward PE
0/-
PEG ratio
0
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Revenue (USD)
05M10M15M20M06 Q407 Q107 Q207 Q307 Q408 Q108 Q208 Q308 Q409 Q1
NTII Revenue (USD) by quarter
PeriodRevenue (USD)
09 Q16.03M
08 Q416.28M
08 Q33.01M
08 Q23.49M
08 Q13.56M
07 Q43.51M
07 Q33.68M
07 Q23.66M
07 Q13.9M
06 Q43.99M
Net Income (USD)
-10M010M20M06 Q407 Q107 Q207 Q307 Q408 Q108 Q208 Q308 Q409 Q1
NTII Net Income (USD) by quarter
PeriodNet Income (USD)
09 Q15.41M
08 Q414.15M
08 Q3-431K
08 Q2-7.84M
08 Q1-2.76M
07 Q4-3.45M
07 Q3-5.06M
07 Q2-6.88M
07 Q1-921K
06 Q4-4.19M
Operating Income (USD)
-10M010M20M06 Q407 Q107 Q207 Q307 Q408 Q108 Q208 Q308 Q409 Q1
NTII Operating Income (USD) by quarter
PeriodOperating Income (USD)
09 Q15.15M
08 Q415.09M
08 Q3-282K
08 Q2-8.1M
08 Q1-3.22M
07 Q4-3.79M
07 Q3-4.02M
07 Q2-5.67M
07 Q1-3.22M
06 Q4-5.31M
EBITDA (USD)
-10M010M20M06 Q407 Q107 Q207 Q307 Q408 Q108 Q208 Q308 Q409 Q1
NTII EBITDA (USD) by quarter
PeriodEBITDA (USD)
09 Q15.16M
08 Q414.74M
08 Q3-259K
08 Q2-8.06M
08 Q1-3.17M
07 Q4-3.74M
07 Q3-3.97M
07 Q2-3.87M
07 Q1-2.58M
06 Q4-5.25M
Cash Flows (USD)
-7.5M-5M-2.5M02.5M06 Q407 Q107 Q207 Q307 Q408 Q108 Q208 Q308 Q409 Q1
NTII Cash Flows (USD) by quarter
PeriodCash Flows (USD)
09 Q12.36M
08 Q4-5.09M
08 Q3-3.38M
08 Q2-4.95M
08 Q1-3.01M
07 Q4-4.91M
07 Q3-4.77M
07 Q2-5.12M
07 Q1-5.91M
06 Q4-2.8M
EPS (USD)
-1-0.500.5106 Q407 Q107 Q207 Q307 Q408 Q108 Q208 Q308 Q409 Q1
NTII EPS (USD) by quarter
PeriodEPS (USD)
09 Q10.2
08 Q40.53
08 Q3-0.02
08 Q2-0.29
08 Q1-0.1
07 Q4-0.15
07 Q3-0.19
07 Q2-0.36
07 Q1-0.19
06 Q4-0.98
Expenses (USD)
-5M05M10M15MR&DSG&ACapex06 Q407 Q107 Q207 Q307 Q408 Q108 Q208 Q308 Q409 Q1
NTII Expenses (USD) by quarter
PeriodExpenses (USD)
09 Q1878K
08 Q4995K
08 Q33.29M
08 Q211.59M
08 Q16.79M
07 Q47.31M
07 Q37.7M
07 Q29.33M
07 Q17.12M
06 Q49.33M
Cash & Debt (USD)
020M40M60MCashShort Term Debt06 Q407 Q107 Q207 Q307 Q408 Q108 Q208 Q308 Q409 Q1
NTII Cash & Debt (USD) by quarter
PeriodCash & Debt (USD)
09 Q126.49M
08 Q424.05M
08 Q321.6M
08 Q223.31M
08 Q128.18M
07 Q429.98M
07 Q334.55M
07 Q252.79M
07 Q18.43M
06 Q48.9M
Debt ratios
-10-50506 Q407 Q107 Q207 Q307 Q408 Q108 Q208 Q308 Q409 Q1
NTII Debt ratios by quarter
PeriodDebt ratios
09 Q1-2.29
08 Q4-7.39
08 Q31.42
08 Q21.23
08 Q11.91
07 Q42.12
07 Q32.21
07 Q23.27
07 Q10.27
06 Q40.58
Margins
0%50%100%150%06 Q407 Q107 Q207 Q307 Q408 Q108 Q208 Q308 Q409 Q1
NTII Margins by quarter
PeriodMargins
09 Q1100%
08 Q4100%
08 Q3100%
08 Q2100%
08 Q1100%
07 Q4100%
07 Q3100%
07 Q2100%
07 Q1100%
06 Q4100%
Return on Capital
-100%-50%0%50%100%06 Q407 Q107 Q207 Q307 Q408 Q108 Q208 Q308 Q409 Q1
NTII Return on Capital by quarter
PeriodReturn on Capital
09 Q118.56%
08 Q460.11%
08 Q3-5.36%
08 Q2-94.32%
08 Q1-16.02%
07 Q4-17.03%
07 Q3-22.05%
07 Q2-24.74%
07 Q14.5%
06 Q418.95%
Shares Outstanding
010M20M30M06 Q407 Q107 Q207 Q307 Q408 Q108 Q208 Q308 Q409 Q1
NTII Shares Outstanding by quarter
PeriodShares Outstanding
09 Q126.93M
08 Q426.93M
08 Q326.93M
08 Q226.92M
08 Q126.92M
07 Q423.18M
07 Q326.91M
07 Q219.31M
07 Q14.77M
06 Q44.29M
Dividends (USD)
00.20.40.60.8Nov 09Dec 09Dec 12
NTII Dividends (USD) by quarter
PeriodDividends (USD)
Dec 120.05
Dec 090.18
Nov 090.75
Book Value Per Share (USD)
-6-4-20206 Q407 Q107 Q207 Q307 Q408 Q108 Q208 Q308 Q409 Q1
NTII Book Value Per Share (USD) by quarter
PeriodBook Value Per Share (USD)
09 Q11.08
08 Q40.87
08 Q30.3
08 Q20.31
08 Q10.64
07 Q40.88
07 Q30.85
07 Q21.44
07 Q1-4.28
06 Q4-5.15
Total Assets (USD)
020M40M60M06 Q407 Q107 Q207 Q307 Q408 Q108 Q208 Q308 Q409 Q1
NTII Total Assets (USD) by quarter
PeriodTotal Assets (USD)
09 Q129.78M
08 Q424.66M
08 Q329.32M
08 Q232.88M
08 Q139.34M
07 Q443.19M
07 Q347.84M
07 Q254M
07 Q111.49M
06 Q410.92M
PE Ratio
0000med 0Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
NTII PE Ratio by quarter
PeriodPE Ratio
Sep 260
Sep 260
Aug 260
Aug 260
Aug 260
Aug 260
Jul 260
Jul 260
Jul 260
Jul 260
Jul 260
Jun 260
Jun 260
Jun 260
Jun 260
May 260
May 260
May 260
May 260
May 260
Apr 260
Apr 260
Apr 260
Apr 260
Mar 260
Mar 260
Mar 260
Mar 260
Feb 260
Feb 260
Feb 260
Feb 260
Jan 260
Jan 260
Jan 260
Jan 260
Jan 260
Dec 250
Dec 250
Dec 250
Dec 250
Nov 250
Nov 250
Nov 250
Nov 250
Oct 250
Oct 250
Oct 250
Oct 250
Oct 250
Sep 250
Sep 250
Sep 250
Sep 250
Aug 250
Aug 250
Aug 250
Aug 250
Aug 250
Jul 250
Jul 250
Jul 250
Jul 250
Jun 250
Jun 250
Jun 250
Jun 250
May 250
May 250
May 250
May 250
May 250
Apr 250
Apr 250
Apr 250
Apr 250
Mar 250
Mar 250
Mar 250
Mar 250
Feb 250
Feb 250
Feb 250
Feb 250
Jan 250
Jan 250
Jan 250
Jan 250
Jan 250
Dec 240
Dec 240
Dec 240
Dec 240
Nov 240
Nov 240
Nov 240
Aug 240
Jul 240
Dec 230
Dec 230
Free Cash Flow Yield
-60000000%-40000000%-20000000%0%med -410731.54%Jan 25May 25Sep 25Jan 26May 26Sep 26
NTII Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-410731.54%
Sep 26-410731.54%
Aug 26-410731.54%
Aug 26-41073152.62%
Aug 26-410731.54%
Aug 26-410731.54%
Jul 26-410731.54%
Jul 26-410731.54%
Jul 26-410731.54%
Jul 26-410731.54%
Jul 26-410731.54%
Jun 26-410731.54%
Jun 26-410731.54%
Jun 26-410731.54%
Jun 26-410731.54%
May 26-410731.54%
May 26-410731.54%
May 26-410731.54%
May 26-410731.54%
May 26-410731.54%
Apr 26-410731.54%
Apr 26-410731.54%
Apr 26-410731.54%
Apr 26-410731.54%
Mar 26-410731.54%
Mar 26-410731.54%
Mar 26-410731.54%
Mar 26-410731.54%
Feb 26-410731.54%
Feb 26-410731.54%
Feb 26-410731.54%
Feb 26-410731.54%
Jan 26-410731.54%
Jan 26-410731.54%
Jan 26-410731.54%
Jan 26-410731.54%
Jan 26-410731.54%
Dec 25-410731.54%
Dec 25-410731.54%
Dec 25-410731.54%
Dec 25-410731.54%
Nov 25-410731.54%
Nov 25-410731.54%
Nov 25-41073152.62%
Nov 25-410731.54%
Oct 25-410731.54%
Oct 25-410731.54%
Oct 25-410731.54%
Oct 25-410731.54%
Oct 25-410731.54%
Sep 25-410731.54%
Sep 25-410731.54%
Sep 25-410731.54%
Sep 25-410731.54%
Aug 25-410731.54%
Aug 25-410731.54%
Aug 25-410731.54%
Aug 25-410731.54%
Aug 25-410731.54%
Jul 25-410731.54%
Jul 25-410731.54%
Jul 25-410731.54%
Jul 25-410731.54%
Jun 25-410731.54%
Jun 25-410731.54%
Jun 25-410731.54%
Jun 25-410731.54%
May 25-410731.54%
May 25-410731.54%
May 25-410731.54%
May 25-410731.54%
May 25-410731.54%
Apr 25-410731.54%
Apr 25-410731.54%
Apr 25-410731.54%
Apr 25-410731.54%
Mar 25-410731.54%
Mar 25-410731.54%
Mar 25-410731.54%
Mar 25-410731.54%
Feb 25-410731.54%
Feb 25-410731.54%
Feb 25-410731.54%
Feb 25-410731.54%
Jan 25-410731.54%
Jan 25-410731.54%
Jan 25-410731.54%
Jan 25-410731.54%
Jan 25-410731.54%
Dec 24-410731.54%
Dec 24-410731.54%
Dec 24-410731.54%
Dec 24-410731.54%
Nov 24-410731.54%
Nov 24-410731.54%
Nov 24-410731.54%
Aug 24-410731.53%
Jul 24-410731.53%
Dec 23-82146.31%
Dec 23-82146.31%
Price to Sales
0000med 0Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
NTII Price to Sales by quarter
PeriodPrice to Sales
Sep 260
Sep 260
Aug 260
Aug 260
Aug 260
Aug 260
Jul 260
Jul 260
Jul 260
Jul 260
Jul 260
Jun 260
Jun 260
Jun 260
Jun 260
May 260
May 260
May 260
May 260
May 260
Apr 260
Apr 260
Apr 260
Apr 260
Mar 260
Mar 260
Mar 260
Mar 260
Feb 260
Feb 260
Feb 260
Feb 260
Jan 260
Jan 260
Jan 260
Jan 260
Jan 260
Dec 250
Dec 250
Dec 250
Dec 250
Nov 250
Nov 250
Nov 250
Nov 250
Oct 250
Oct 250
Oct 250
Oct 250
Oct 250
Sep 250
Sep 250
Sep 250
Sep 250
Aug 250
Aug 250
Aug 250
Aug 250
Aug 250
Jul 250
Jul 250
Jul 250
Jul 250
Jun 250
Jun 250
Jun 250
Jun 250
May 250
May 250
May 250
May 250
May 250
Apr 250
Apr 250
Apr 250
Apr 250
Mar 250
Mar 250
Mar 250
Mar 250
Feb 250
Feb 250
Feb 250
Feb 250
Jan 250
Jan 250
Jan 250
Jan 250
Jan 250
Dec 240
Dec 240
Dec 240
Dec 240
Nov 240
Nov 240
Nov 240
Aug 240
Jul 240
Dec 230
Dec 230
EV/EBITDA
-2.29-2.29-2.29-2.28med -2.29Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
NTII EV/EBITDA by quarter
PeriodEV/EBITDA
Sep 26-2.29
Sep 26-2.29
Aug 26-2.29
Aug 26-2.29
Aug 26-2.29
Aug 26-2.29
Jul 26-2.29
Jul 26-2.29
Jul 26-2.29
Jul 26-2.29
Jul 26-2.29
Jun 26-2.29
Jun 26-2.29
Jun 26-2.29
Jun 26-2.29
May 26-2.29
May 26-2.29
May 26-2.29
May 26-2.29
May 26-2.29
Apr 26-2.29
Apr 26-2.29
Apr 26-2.29
Apr 26-2.29
Mar 26-2.29
Mar 26-2.29
Mar 26-2.29
Mar 26-2.29
Feb 26-2.29
Feb 26-2.29
Feb 26-2.29
Feb 26-2.29
Jan 26-2.29
Jan 26-2.29
Jan 26-2.29
Jan 26-2.29
Jan 26-2.29
Dec 25-2.29
Dec 25-2.29
Dec 25-2.29
Dec 25-2.29
Nov 25-2.29
Nov 25-2.29
Nov 25-2.29
Nov 25-2.29
Oct 25-2.29
Oct 25-2.29
Oct 25-2.29
Oct 25-2.29
Oct 25-2.29
Sep 25-2.29
Sep 25-2.29
Sep 25-2.29
Sep 25-2.29
Aug 25-2.29
Aug 25-2.29
Aug 25-2.29
Aug 25-2.29
Aug 25-2.29
Jul 25-2.29
Jul 25-2.29
Jul 25-2.29
Jul 25-2.29
Jun 25-2.29
Jun 25-2.29
Jun 25-2.29
Jun 25-2.29
May 25-2.29
May 25-2.29
May 25-2.29
May 25-2.29
May 25-2.29
Apr 25-2.29
Apr 25-2.29
Apr 25-2.29
Apr 25-2.29
Mar 25-2.29
Mar 25-2.29
Mar 25-2.29
Mar 25-2.29
Feb 25-2.29
Feb 25-2.29
Feb 25-2.29
Feb 25-2.29
Jan 25-2.29
Jan 25-2.29
Jan 25-2.29
Jan 25-2.29
Jan 25-2.29
Dec 24-2.29
Dec 24-2.29
Dec 24-2.29
Dec 24-2.29
Nov 24-2.29
Nov 24-2.29
Nov 24-2.29
Aug 24-2.29
Jul 24-2.29
Dec 23-2.29
Dec 23-2.29
Price/Operating Cashflow
0204060med 14.18Feb 02Apr 06Jun 06Sep 06Nov 06Jan 07Mar 07
NTII Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Mar 076.85
Mar 078.39
Mar 078.26
Mar 078.33
Mar 078.45
Feb 078.33
Feb 078.55
Feb 078.58
Feb 078.36
Jan 077.64
Jan 077.38
Jan 077.07
Jan 077.07
Dec 066.47
Dec 066.47
Dec 066.76
Dec 067.44
Dec 067.15
Nov 068.73
Nov 068.95
Nov 067.73
Nov 066.99
Oct 067.09
Oct 067.44
Oct 067.73
Oct 067.73
Sep 067.63
Sep 0612.43
Sep 0614.12
Sep 0614.13
Sep 0615.02
Aug 0614.01
Aug 0614.54
Aug 0614.3
Aug 0615.86
Jul 0614.54
Jul 0614.23
Jul 0613.91
Jul 0614.81
Jun 0614.7
Jun 0613.88
Jun 0615.43
Jun 0619.4
Jun 0619.05
May 0617.98
May 0617.8
May 0618.93
May 0620.41
Apr 0620.89
Apr 0620.89
Apr 0621.3
Apr 0621.78
Mar 0621
Mar 0258.34
Mar 0257.61
Mar 0258.34
Mar 0256.52
Mar 0257.49
Feb 0258.1
Feb 0249.62
Feb 0253.86
Feb 0255.67
Jan 0258.34
Jan 0257.49
Jan 0258.7
Jan 0258.7
Price to Book
0000med 0Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
NTII Price to Book by quarter
PeriodPrice to Book
Sep 260
Sep 260
Aug 260
Aug 260
Aug 260
Aug 260
Jul 260
Jul 260
Jul 260
Jul 260
Jul 260
Jun 260
Jun 260
Jun 260
Jun 260
May 260
May 260
May 260
May 260
May 260
Apr 260
Apr 260
Apr 260
Apr 260
Mar 260
Mar 260
Mar 260
Mar 260
Feb 260
Feb 260
Feb 260
Feb 260
Jan 260
Jan 260
Jan 260
Jan 260
Jan 260
Dec 250
Dec 250
Dec 250
Dec 250
Nov 250
Nov 250
Nov 250
Nov 250
Oct 250
Oct 250
Oct 250
Oct 250
Oct 250
Sep 250
Sep 250
Sep 250
Sep 250
Aug 250
Aug 250
Aug 250
Aug 250
Aug 250
Jul 250
Jul 250
Jul 250
Jul 250
Jun 250
Jun 250
Jun 250
Jun 250
May 250
May 250
May 250
May 250
May 250
Apr 250
Apr 250
Apr 250
Apr 250
Mar 250
Mar 250
Mar 250
Mar 250
Feb 250
Feb 250
Feb 250
Feb 250
Jan 250
Jan 250
Jan 250
Jan 250
Jan 250
Dec 240
Dec 240
Dec 240
Dec 240
Nov 240
Nov 240
Nov 240
Aug 240
Jul 240
Dec 230
Dec 230
Neurobiological Technologies, Inc.
NTII
Stockpicker

Video analysis: NTII

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.